ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2645

The Internalization of DNA-Antibodies By Podocytes during Lupus Nephritis

Anja Römer-Hillmann1, Elisabeth Jung2, Annika Engbers1, Marcel Reinhardt1, Hedda Wardemann3, Thomas Pap4 and Annett Jacobi5, 1Institute of Musculoskeletal Medicine, University Hospital Muenster, Muenster, Germany, 2Department of Internal Medicine D, Rheumatology, University Hospital Muenster, Muenster, Germany, 3Deutsches Krebsforschungszentrum, Heidelberg, Germany, 4Institute for Musculoskeletal Medicine, University Hospital Muenster, Muenster, Germany, 5Internal Medicine, Ruppiner Kliniken GmbH, Neuruppin, Germany

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: anti-dsDNA and nephritis, SLE

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: Systemic Lupus Erythematosus – Human Etiology and Pathogenesis Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Podocytes are postmitotic visceral epithelial cells, located at the Bowmans capsule of the kidney building up the slit diaphragm with their foot processes to filtrate the blood and keep valuable large proteins in the vessels. Loss of these cells leads to proteinuria.

In Systemic Lupus Erythematosus (SLE) different organs are affected by autoantibodies which results in chronic inflammation and a high percentage of patients develop Lupus nephritis (LN) resulting in podocyte damage and disruption of the slit diaphragm. The risk for LN correlates directly with the level of anti-double stranded DNA antibodies (adsDNAabs).

Methods:

In this study, we wanted to identify the direct effect of adsDNAabs on podocytes.

We established an in vitro system to investigate the specific impact of monoclonal antibodies and their immune complexes directly on podocytes (AB8 cell line). Monoclonal antibodies were generated by transfecting HEK293T cell line with Ig heavy and corresponding light chain encoding plasmid DNA obtained from single B cells of patients with SLE and LN. Podocytes were incubated with the produced monoclonal antibodies and the internalization process and functional consequences were analyzed by immunofluorescence, Western Blot, FACS and electron microscopy. For comparison, primary podocytes were isolated from LN patient urine and analyzed by immunofluorescence. To clarify the endocytotic pathway of antibody internalization, cells were treated either with chlorpromazine, MDC or nystatin.

Results:

The recombinantly produced adsDNAabs from LN patients were specific against nuclear structures and build complexes with double stranded DNA, essential for the internalization by cultivated podocytes. Interestingly, viability and migratory capacity were not influenced by the exposure to adsDNAabs for 48h. The internalized antibodies were enclosed by membranous structures and reach the cytosol via clathrin dependent endocytosis. The process of internalization was time and dose dependent and reversible. Furthermore, internalized antibody complexes could also be detected in primary human LN podocytes.

Conclusion:

In our in vitro model the specific uptake of adsDNAabs was observed, in line with human LN data. Podocytes from patients with LN show IgG positive aggregates in the cytosol. The internalization depends on the complex formation of the antibodies with dsDNA and could be important part of the LN pathogenesis.


Disclosure: A. Römer-Hillmann, None; E. Jung, None; A. Engbers, None; M. Reinhardt, None; H. Wardemann, None; T. Pap, Orthogen, 5; A. Jacobi, None.

To cite this abstract in AMA style:

Römer-Hillmann A, Jung E, Engbers A, Reinhardt M, Wardemann H, Pap T, Jacobi A. The Internalization of DNA-Antibodies By Podocytes during Lupus Nephritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/the-internalization-of-dna-antibodies-by-podocytes-during-lupus-nephritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-internalization-of-dna-antibodies-by-podocytes-during-lupus-nephritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology